Former UFC fighter Jonathan Goulet opens up about long battle with depression: ‘I was suffering inside’  The Athletic

Source/Disclosures Published by: Disclosures: Tharmathurai and colleagues report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe

If someone contracts the Covid-19 virus, the road to recovery is not an easy process. First, the person needs to isolate themselves from other members in their house. This puts patients in a tough spot because now, their daily life comes to a halt and social interaction becomes limited. If this person has been diagnosed

New York, May 04, 2021 (GLOBE NEWSWIRE) — The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression” on Tuesday, May 11, 2021, from 2pm to 3pm ET. The presenter will be Nolan R. Williams, M.D., Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University

ALPENA, Mich. – May is Mental Health Awareness Month. A national mental health survey found that 83 percent of those diagnosed with depression say life would be easier if others could understand what they’re going through. Medical experts say new technologies could help more people understand the illness, even those who don’t suffer from depression.

The term “masked depression” was once used to describe a condition where a person with depression experienced physical symptoms, called somatic or somatoform symptoms, without feeling the psychological or mood symptoms typically associated with it. Masked depression isn’t used as a diagnosis anymore. Its popularity peaked during the 1970s and 80s, and it has since

An investigational N-methyl-D-aspartate (NMDA)-receptor antagonist was effective at treating major depressive disorder in the phase III GEMINI trial. The 1:1 randomized controlled study of 327 adults with major depression found that twice-daily, oral treatment with the dextromethorphan-bupropion tablet (AXS-05) resulted in a significant reduction in total Montgomery-Åsberg Depression Rating Scale (MADRS) score versus placebo, reported

Health Beat: Clinical depression | Video | wfmz.com  WFMZ Allentown

May is national Mental Health Awareness month, and a doctor wants to clear up the stigma around depression and give suggestions on how to support those experiencing it. May is national Mental Health Awareness Month, and a doctor wants to clear up the stigma around depression and give suggestions on how to support those experiencing

Introduction Rheumatoid arthritis (RA), a multi-systemic, chronic inflammatory disease characterized by symmetrical peripheral polyarthritis with or without extra-articular involvement is a debilitating autoimmune disease with an estimated prevalence ranging from 0.5 to 1% in developed countries.1 The burden of this progressive disease in developing countries is largely unknown. RA is associated with a number of